Market Watch Highlights: Olema Pharmaceuticals Inc (OLMA) Ends on an Upturn Note at 11.63

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Olema Pharmaceuticals Inc’s stock clocked out at $11.63, up 1.84% from its previous closing price of $11.42. In other words, the price has increased by $1.84 from its previous closing price. On the day, 2.7 million shares were traded. OLMA stock price reached its highest trading level at $11.77 during the session, while it also had its lowest trading level at $11.27.

Ratios:

To gain a deeper understanding of OLMA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.61 and its Current Ratio is at 9.61. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.

On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.

On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 04 ’24 when Graham G. Walmsley sold 1,175,000 shares for $14.85 per share. The transaction valued at 17,448,750 led to the insider holds 700,761 shares of the business.

Harmon Cyrus sold 5,000 shares of OLMA for $61,650 on Jun 04 ’24. The Director now owns 781,283 shares after completing the transaction at $12.33 per share. On Jun 03 ’24, another insider, Harmon Cyrus, who serves as the Director of the company, sold 5,000 shares for $10.93 each. As a result, the insider received 54,650 and left with 786,283 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 650510080 and an Enterprise Value of 403273120.

Stock Price History:

Over the past 52 weeks, OLMA has reached a high of $17.79, while it has fallen to a 52-week low of $7.68. The 50-Day Moving Average of the stock is 8.08%, while the 200-Day Moving Average is calculated to be -6.33%.

Shares Statistics:

It appears that OLMA traded 921.66K shares on average per day over the past three months and 1089150 shares per day over the past ten days. A total of 54.99M shares are outstanding, with a floating share count of 48.62M. Insiders hold about 13.08% of the company’s shares, while institutions hold 96.09% stake in the company. Shares short for OLMA as of 1715731200 were 8539476 with a Short Ratio of 8.86, compared to 1713139200 on 8974804. Therefore, it implies a Short% of Shares Outstanding of 8539476 and a Short% of Float of 26.99.

Most Popular